NeuroMetrix Reports Growing Support by Healthcare Professionals for Quell™ Wearable Pain Relief Technology

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NURO), an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders, today reported progress in enlisting clinicians to dispense and recommend Quell. Quell is available for direct purchase at www.quellrelief.com and at select physicians' offices. The company recently announced an agreement with Advantage Consumer Healthcare to guide expansion into mass merchandisers, chain drug stores and other retail opportunities.

"As a premium priced, cutting edge technology, gaining healthcare professional endorsement for Quell is critical," said Frank McGillin, NeuroMetrix Senior VP and General Manager, Consumer. "Patients often rely on healthcare professionals to help them identify the best pain management options. Professional endorsement provides credibility and is a competitive differentiator."

The company has been focused on development of a healthcare professional distribution channel. Recent highlights include:

• A test of direct sales to practitioners in six major urban areas has succeeded with over 275 healthcare practices now enrolled and dispensing Quell in their offices.
• Quell has been presented at healthcare conferences across multiple specialties. It was well received at the recent Annual Scientific Meeting of the American Podiatric Medical Association (APMA) where the NeuroMetrix booth was one of the most active and a meaningful number of new accounts were signed. It will be showcased at the Florida Chiropractic Association National ConventionAugust 27-30, at PAINWeek in Las VegasSeptember 8-12 targeting pain management specialists, and at the Pri-Med East Annual Conference in BostonSeptember 17-20 which focuses on primary care physicians.
• Quell was included in The Top Ten Innovations In Podiatry, chosen by "Podiatry Today".
• A Quell Medical Advisory Board has been assembled to provide market and product development guidance, as well as informed spokespersons. The Board is comprised of clinical and academic leaders across several medical specialties.

"It's so nice to finally have an adjunct to my treatment plans for patients with chronic painful musculoskeletal problems," said Marlene Reid, DPM, a foot and ankle surgeon and past president of the Illinois Podiatric Medical Association. "Most of my patients want an alternative to taking pain meds and Quell has proven to be that alternative. My patients appreciate the convenience of having an option that is readily available in my office and often relate that it is helpful to all of their painful conditions, not just what I may be treating."

About Quell Wearable Pain Relief Technology

Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This first-of-its-kind wearable device utilizes NeuroMetrix's patented, wearable intensive nerve stimulation (WINS) technology to provide drug-free pain relief. It is designed for people with nerve pain, sciatica, osteoarthritis and fibromyalgia, among other conditions. Quell is currently available through select healthcare professionals and online at www.QuellRelief.com.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150813005726/en/

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

News Provided by Acquire Media